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Letters to the Editors
Reply
Sirs,
I read with great interest the study by 
Pisoni et al., which sheds another light on 
the management of leflunomide. It confirms 
that findings of clinical and epidemiologi-
cal studies may vary according to various 
parameters such as patient characteristics 
and conditions of treatment, which are 
mostly country-dependent. These discrep-
ancies highlight the importance of repeat-
ing pharmacoepidemiologic studies in each 
country to take into account treatment pat-
terns which may play a role in the actual 
efficacy and safety of drugs.
Several remarks can be made. The popula-
tion in Pisoniʼs study was quite similar to 
ours and confirms differences with the pop-
ulation included in clinical trials. Neverthe-
less, the severity of the disease and prior 
treatment seem to be different. Moreover, 
there appear to be differences in the man-
agement of adverse events (stopping the 
treatment in our study and reduction of the 
daily dose or continuation of the treatment 
in Pisoniʼs study). In the Italian cohort, only 
17.9% of the patients had previously re-
ceived a loading dose and the dose of leflu-
nomide was adjustable as the occasion may 
have required. The authors seem to explain 
the lower discontinuation rate by the lower 
leflunomide dose (lower daily dose without 
previous loading dose). Era et al: (1) did 
not find any significant association between 
loading dose and the presence of adverse 
events but the number of patients included 
in their study was too small to draw definite 
conclusions on this point.
Poor et al. (2) found a better efficacy profile 
with the 20 mg daily dose than with 10 mg. 
As the two parameters (efficacy and safety) 
should be taken into account in the treat-
ment, it is difficult draw a conclusion re-
garding the best approach. In any case, large 
prospective studies or studies focusing on 
the role of the dose regimen should be con-
ducted in order to improve our knowledge 
on leflunomide and the best way to manage 
long-term treatment in real-life settings.
Dr. K. MARTIN, PharmD, PhD
Department of Pharmacology, Bordeaux 2 
University, Inserm U657, France.
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Level of agreement between 
rheumatologists on US image 
acquisition using a 3D volumetric 
probe
Sirs,
In recent times, technological advances have 
enabled the ultrasound (US) exploration of 
small joints and superficial soft tissues with 
high-frequency volumetric probes. They 
provide the possibility to acquire an infinite 
number of 2D US images within a 3D data 
set generated automatically, which propos-
es to rectify the operator dependency of US 
in the acquisition process (1, 2). A consen-
sus meeting was convened in Barcelona on 
the 28th of January 2006 for the purpose of 
verifying that the image acquisition proc-
ess using a 3D volumetric probe is operator 
independent.
This was the initial step for clarifying the 
methodology for a multi-centre internation-
al study on hand arthritis.
All the participants (9 experienced rheu-
matologist sonographers and a rheumatolo-
gist with no previous US experience) were 
asked to acquire 3D data sets of the second 
metacarpophalangeal (MCP) joint in a sin-
gle healthy subject as follows: dorsal and 
volar approaches with hand in the neutral 
position and dorsal approach with the hand 
held in full flexion at the MCP joints.
The acquisition of the 3D data sets was car-
ried out using a Logiq 9 system (General 
Electrics Medical Systems, Milwaukee, 
WI) equipped with the 4D16L 3D probe.
Attention was paid to the correct anatomi-
cal positioning of the subject together with 
the use of an adequate amount of acoustic 
gel.
The 3D data sets were processed collec-
tively using dedicated 3D Viewer software 
(Centricity Radiology RA 600 Version 6.1) 
compatible with standard personal comput-
ers, in order to select the most representa-
tive US images of the following standard 
scans: longitudinal dorsal scan with MCP 
joint in neutral position and fully flexed.
Two sets of mosaic were constructed con-
taining the selected US images correspond-
ing to the above standard scans.
According to the Delphi method (3), the 
participants were asked to state their level of 
agreement on the fact that the US images in 
the mosaics were similar in their depiction 
of longitudinal dorsal scan, bone profile, ex-
tensor tendon and articular cartilage.
Moreover, the level of agreement was test-
ed in comparing the US images acquired by 
the inexperienced rheumatologist to those 
of the experienced rheumatologist sonog-
raphers.
The Delphi method uses a semi-quantitative 
scale ranging from 1 (strong disagreement) 
to 6 (strong agreement).
The table reports the mean values and 
standard deviations of the scores.
The results of this consensus meeting 
clearly show the concordance between in-
dependent operators in the acquisition of 
3D US imagery. In addition, we have also 
demonstrated that previous US experience 
or skills are not necessary for obtaining 
US images indistinguishable from those 
of the experts. This is the first exercise to 
verify the operator independent nature of 
the 3D volumetric probe in acquiring US 
images of the MCP joint. Similar evidence 
in other anatomical sites should be gathered 
to evaluate the full potential of 3D US in 
rheumatology.
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Table
Anatomical target Mean Standard deviation Median
 
Longitudinal dorsal scan 5.75 0.34 6 
Bone profile 5.55 0.42 5.5 
Extensor tendon 5.55 0.52 5.75 
Articular cartilage 5.5 0.45 5.5 
Total 5.59 0.08 5.6
